Risk of Nerve Damage After Administration of Local Anesthesia

Status unconfirmed · Phase 1

Conditions studied: Inferior Alveolar Nerve Injuries

In brief

This research aims to evaluate of the risk of nerve damage following the administration of articaine 4% and lidocaine 2% for Inferior Alveolar nerve Block (IANB). A Randomized Controlled Clinical Trial will be conducted where the patient will be randomly assigned to one the two groups; articaine 4% and Lidocaine 2%. The type of LA will be concealed to the operator, investigators and assessors. The patients will be monitored for any aigns of nerve parathesia for 3 months after the procedure.

Key facts

Study ID

NCT06564987

Run by

Cleveland Dental Institute

People needed

80

Starts

2024-01-01

Expected to finish

2025-03-31

Last updated by the study team

2024-08-26

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients with age between 18-55 years old
• Patients need IANB
• healthy patient

You may not qualify if…

• medical conditions
• allergies
• medications
• pregnancy and breastfeeding
• inability to provide informed consent
• specific dental or medical history.

Where it is running

• Cleveland Dental Institute — Akron, Ohio, United States (enrolling)
• Cleveland Dental Institute — Ashtabula, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.